Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Nakayama

Showing results (1-10 of 278) with videos related to

Pageof 28
Sort By:
Cellular Immunology|August 1, 1984
Lyt phenotype of cytotoxic T cells: shift from Lyt-1+2+3+ to a mixed population of Lyt-1+2+3+ and Lyt-1-2+3+ during in vitro cultureE Nakayama, A Uenaka
The Journal of Experimental Medicine|February 1, 1985
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionE Nakayama, A Uenaka
The Japanese Journal of Experimental Medicine|October 1, 1977
Reactivity of HLA typing sera against cultured lymphoblastoid cell lines and purified peripheral B and T cells from the same original donorsE Nakayama, K Itakura
Japanese Journal of Cancer Research : Gann|June 1, 1992
Inhibition of B6RV2 leukemia growth by immunization with purified unique antigenA Uenaka, E Nakayama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1995
[Tumor rejection antigen and cancer immunotherapy]T Matsutake, E Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1996
[Analysis of tumor rejection antigen peptides recognized by specific CTL]A Uenaka, E Nakayama
Talanta|February 1, 1987
Determination of ultratrace amounts of cobalt by catalysis of the tiron-hydrogen peroxide reaction with an improved continuous-flow analysis systemK Isshiki, E Nakayama
Frontiers in Microbiology|February 1, 2012
TRIM5α and Species Tropism of HIV/SIVEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|March 22, 2012
Role of Human TRIM5α in Intrinsic ImmunityEmi E Nakayama, Tatsuo Shioda
Uirusu|March 25, 2006
[TRIM5alpha]Emi E Nakayama, Tatsuo Shioda
Pageof 28

Showing results (1-10 of 278) with videos related to

Sort By:
Pageof 28
Cellular Immunology|August 1, 1984
Lyt phenotype of cytotoxic T cells: shift from Lyt-1+2+3+ to a mixed population of Lyt-1+2+3+ and Lyt-1-2+3+ during in vitro cultureE Nakayama, A Uenaka
The Journal of Experimental Medicine|February 1, 1985
Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejectionE Nakayama, A Uenaka
The Japanese Journal of Experimental Medicine|October 1, 1977
Reactivity of HLA typing sera against cultured lymphoblastoid cell lines and purified peripheral B and T cells from the same original donorsE Nakayama, K Itakura
Japanese Journal of Cancer Research : Gann|June 1, 1992
Inhibition of B6RV2 leukemia growth by immunization with purified unique antigenA Uenaka, E Nakayama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1995
[Tumor rejection antigen and cancer immunotherapy]T Matsutake, E Nakayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1996
[Analysis of tumor rejection antigen peptides recognized by specific CTL]A Uenaka, E Nakayama
Talanta|February 1, 1987
Determination of ultratrace amounts of cobalt by catalysis of the tiron-hydrogen peroxide reaction with an improved continuous-flow analysis systemK Isshiki, E Nakayama
Frontiers in Microbiology|February 1, 2012
TRIM5α and Species Tropism of HIV/SIVEmi E Nakayama, Tatsuo Shioda
Frontiers in Microbiology|March 22, 2012
Role of Human TRIM5α in Intrinsic ImmunityEmi E Nakayama, Tatsuo Shioda
Uirusu|March 25, 2006
[TRIM5alpha]Emi E Nakayama, Tatsuo Shioda
Pageof 28